Programme

08:30 Registration opens
09:00 Exhibition and Partnering throughout the day
Exhibition Area
10:00 General Assembly of Swiss Biotech Association
(by invitation only)
Room Shanghai 1+2
11:00 - 12:30 Plenary Session
Room Sydney
Moderation: Monika Jones
11:00 Welcome Address
Dominik Escher, President, Swiss Biotech Association
Michael Altorfer, CEO, Swiss Biotech Association
Keynote I: Creating a Culture of Innovation at Novartis
Vasant Narasimhan, CEO, Novartis AG
Keynote II: Glycart Biotechnology to Roche Innovation Center Zurich: a Journey in Cancer Immunotherapy R&D
Pablo Umaña, Head Cancer Immunotherapy Discovery, Roche Glycart AG
Keynote III: Facing the Future - Rentschler Biopharma SE PDF
Frank Mathias, CEO, Rentschler Biopharma SE
Presentation of the Swiss Biotech Report PDF
Jürg Zürcher, Partner, Ernst & Young
12:30 Lunch sponsored by
13:30 Parallel tracks in the afternoon
13:30 - 16:00 Funding biotech companies - discuss with the experts
Room Delhi
Presented by:
Moderation: Monika Jones
Introduction
Discuss with the Experts
Did you ever ask yourself how funding biotech could be improved? These experts will answer questions and give first-hand insight into this topic.
Martin Rohrbach & Remko Van de Kreeke, KPMG AG (Auditors & Advisors)
Christian Fehr, SIX Swiss Exchange as Stock Exchange Expert
Richard Schindler, Zürcher Kantonalbank as Capital Markets Expert
Dieter Gericke, Homburger AG as Legal Expert
Markus Hosang, BioMedPartners AG as Investor Expert
Peer Nils Schröder, Basilea Pharmaceutica AG as listed Company Expert
Aitana Peire, Venture Valuation as Valuation Company Expert
15:30- 16:00 Wrap-up: Analysis of Survey & Discussion
13:30 - 15:30 Analyst & Investor track
Room Shanghai 1 + 2
Moderation: Bob Pooler, valuationLab AG
Santhera Pharmaceuticals AG, Thomas Meier, CEO PDF
Newron Pharmaceuticals S.p.A., Stefan Weber, CEO PDF
Addex therapeutics ltd., Tim Dyer, CEO PDF
Idorsia Pharmaceuticals ltd, André Muller, CFO PDF
Molecular Partners, AG Patrick Amstutz, CEO PDF
InnoMedica Holding AG, Jonas Zeller, CFO PDF
13:30 - 16:45 Emerging Biotech companies
Room Kairo 1+2
presented by:

Moderation: Martin Heldt, VP & General Manager, IQVIA Switzerland

IQVIA Company Overview Presentation
Martin Heldt, VP & General Manager PDF
TOPADUR PHARMA AG, Reto Naef, CEO and founder PDF
Vaxxilon AG, Tom Monroe, CEO PDF
Therachon AG, Christian Meyer, CEO
Heptares Therapeutics Zürich Ltd., Carlo Bertozzi, Director of Operations PDF
Cellestia Biotech AG, Michael Bauer, CEO PDF
SynDermix AG, Dieter Hemmer, CEO PDF
Legacy Healthcare SA, Marcos Val, CFO PDF
CDR-Life AG, Christian Leisner, CEO PDF
IQVIA Presentation on Drug Development Strategy, Clinical Development, Asset Valuation & Due Diligence
Martin Heldt, Vp & General Manager
Tim Wintermantel, Head Real World Insights Services, Switzerland
Max Rubin, Senior Principal, Strategy and portfolio Analysis
DXC RT AG, Maëlle Garnier, Project Manager PDF
Lunaphore Technologies SA, Andrea Büchler, Finance & Business Development Manager PDF
SimplicityBio SA, Matthew Hall, CEO and Co-founder PDF
Biognosys AG, Oliver Rinner, CEO PDF
SOPHiA GENETICS SA, Esteban Czwan, VP Business Development
certus molecular diagnostics ag, Tim Pfister, CFO PDF
IQVIA Presentation on Commercialization
Paolo Molinari, Head Commercial Effectiveness Services, Switzerland
16:45 Wrap-up and close
15:00 - 16:45 International R&D Cooperation Forum with a Focus on UK
Room Shanghai 3

presented by:

Download all presentations for this track here
Switzerland and the UK leading the Way for international R&D: how to benefit from this Springboard?
Liv Minder, Director Investment Promotion, Switzerland Global Enterprise
Noel McEvoy, Director, Department of international trade Switzerland
Christof Klöpper, Senior project Manager, Switzerland innovation
Case Study: a Unique Ecosystem for Successful International Collaboration in Oncology
Venkat Reddy, VP Global Head of Translational Sciences, Glenmark Pharmaceuticals
Oliver Philippe, Head of Business Development & Corporate relations, Biopôle
Antoine Jourdan, Director, Switzerland Innovation Park Network west EPFL
Looking for Collaborations in Switzerland: UK Companies Pitch
Pharm-Olam, Pharmaron, Janssen Oncology, LifeArc, Antimicrobial resistance Centre, ARCINOVA
16:45 End of Track
17:00 - 19:00 Swiss Biotech Associations's 20th anniversary celebration
Exhibition Area
17:00 Swiss Biotech Associations's 20th anniversary celebration with aperó riche and launch of Swiss Biotech Success Stories
Swiss Biotech Association cordially invites you to join us for our 20th anniversary celebration and the launch of the Swiss Biotech Success Stories campaign. Embedded in Switzerland’s leading biotechnology conference – the Swiss Biotech Day – this evening event will entertain you with an exclusive programme, honoring and celebrating significant contributions to Switzerland’s biotech industry, accompanied by an apéro riche and plenty of room for networking.
19:00 End